Redsense Medical AB's revenue for the
three
months ended in Mar. 2026 was $0.69 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $2.73 Mil.
Redsense Medical AB's Revenue per Share for the
three
months ended in Mar. 2026 was $0.04.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.17.
Warning Sign:
Redsense Medical AB revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Redsense Medical AB was -18.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 22.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Redsense Medical AB's highest 3-Year average Revenue per Share Growth Rate was 91.30% per year. The lowest was -2.20% per year. And the median was 25.15% per year.
Redsense Medical AB (OTCPK:RDSNF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Redsense Medical AB Revenue Related Terms
Redsense Medical AB Revenue Historical Data
* Premium members only.
The historical data trend for Redsense Medical AB's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Redsense Medical AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redsense Medical AB Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Redsense Medical AB's Revenue distribution charts can be found below:
* The bar in red indicates where Redsense Medical AB's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redsense Medical AB (RDSNF) has a Revenue of $2.73 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Redsense Medical AB and its competitors.
Is Redsense Medical AB's Revenue too high?
Redsense Medical AB's current Revenue is $2.73 Mil. Overall, Redsense Medical AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's Revenue compare to ABT and SYK?
Redsense Medical AB's Revenue of $2.73 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Redsense Medical AB and its competitors. Redsense Medical AB's current Revenue is $2.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current Revenue of $2.73 Mil. The stock's GF Value™ is $0.82, compared to a current price of $0.51 — trading 37.8% below its estimated fair value. The current Revenue is $2.73 Mil. Redsense Medical AB's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current Revenue is $2.73 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redsense Medical AB (RDSNF) Overvalued in 2026?
Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued.
The current stock price of $0.51 is trading 37.8% below its estimated GF Value™ of $0.82.
Key valuation signals for RDSNF:
Revenue: $2.73 Mil
GF Value™: $0.82 vs. price of $0.51 (37.8% below fair value)
No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
55GF Score
Get the complete analysis for RDSNF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDSNF has been successfully added to your 
